“…Purification of the compound 3 required purification by using column chromatography. The overall yield obtained by this method is greater than earlier reports [13]. 4,5,6,7-Tetrahydro-1H-pyrazolo [4,3-c]pyridine (3) is reacted with di-tert-butyl dicarbonate (Boc anhydride) using triethylamine as base to obtain di-tert-butyl-4,5-di hydro-7H-pyrazolo [3,4-c]pyridine-1,6-dicarboxylate (4) with yield 91%.…”
Section: Chemistrycontrasting
confidence: 45%
“…The obtained crude material was purified by silica gel (100-200 mesh) column chromatography by using 10-40% ethyl acetate:hexane (v:v, 10-40:90-60). The obtained compound was washed with diethyl ether (100 mL) to obtain compound 3 [13]. …”
“…Purification of the compound 3 required purification by using column chromatography. The overall yield obtained by this method is greater than earlier reports [13]. 4,5,6,7-Tetrahydro-1H-pyrazolo [4,3-c]pyridine (3) is reacted with di-tert-butyl dicarbonate (Boc anhydride) using triethylamine as base to obtain di-tert-butyl-4,5-di hydro-7H-pyrazolo [3,4-c]pyridine-1,6-dicarboxylate (4) with yield 91%.…”
Section: Chemistrycontrasting
confidence: 45%
“…The obtained crude material was purified by silica gel (100-200 mesh) column chromatography by using 10-40% ethyl acetate:hexane (v:v, 10-40:90-60). The obtained compound was washed with diethyl ether (100 mL) to obtain compound 3 [13]. …”
“…[4][5][6][7][8][9][10][11][12] The major drawback of this approach relates to regioselectivity issues when a substituent is needed at one of the pyrazole ring nitrogen atoms. 4,6,11 In this work, we report an alternative and regioselective approach to derivatives of 1, 4 and 5, involving annulation of the heteroaliphatic ring to the corresponding polysubstituted pyrazole derivative 6, from common, readily available starting materials (Nsubstituted hydrazine, chloroacetone and potassium phthalimide) (Scheme 2).…”
We herein disclose a series of novel diaryl urea derivatives possessing a 4H-pyrido[1,2-a]pyrimidin-4-one group as novel potent anticancer compounds. The structures were confirmed by IR,(1)H-NMR, and MS. All the compounds were screened for their antiproliferative activity against the human breast cancer cell line (MDA-MB-231). The pharmacological results indicated that most of the compounds showed moderate activity. The best of this series is compound 4c (IC(50)= 0.7 micromol/L), with a potency 3.6-fold higher than Sorafenib (IC(50) = 2.5 micromol/L), which was approved in 2005.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.